Descriptive Analysis of Long- and Intermediate-Acting Insulin and Key Safety Outcomes in Adults with Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

Descriptive Analysis of Long- and Intermediate-Acting Insulin and Key Safety Outcomes in Adults with Type 2 Diabetes Mellitus

Published:2019-11 Issue:11 Volume:25 Page:1162-1171
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Kent Daniel J.¹,McMahill-Walraven Cheryl N.²,Panozzo Catherine A.³,Pawloski Pamala A.⁴,Haynes Kevin⁵,Marshall James³,Brown Jeffrey³,Eichelberger Bernadette⁶,Lockhart Catherine M.⁶

Affiliation:

1. Kaiser Permanente of Washington, Seattle

2. Aetna, Blue Bell, Pennsylvania

3. Harvard Pilgrim Healthcare Institute, Boston, Massachusetts

4. HealthPartners, Bloomington, Minnesota

5. HealthCore, Wilmington, Delaware

6. Biologics and Biosimilars Collective Intelligence Consortium, Alexandria, Virginia.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Applications of Plant and Nutraceutical-Based Compounds for the Management of Type 2 Diabetes Mellitus: A Narrative Review;Current Diabetes Reviews;2024-02

2. The US Food and Drug Administration Sentinel System: a national resource for a learning health system;Journal of the American Medical Informatics Association;2022-09-12

3. Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort study;British Journal of General Practice;2022-03-15

4. Intravaginal nonablative radiofrequency in the treatment of genitourinary syndrome of menopause symptoms: a single-arm pilot study;BMC Women's Health;2021-10-30